Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement

Set Alert for Reimbursement

Payment Schemes For Innovative Medtech Exist In Just 8 European Countries - Report

Innovative medtech products should receive reimbursement based on the value they add to the health care system, but just eight European countries offer funding pathways at present, analysis by MedTech Europe and Med Tech Reimbursement Consulting shows.

Europe EU

UK Medtech Strategy Before 2022 Year End, Government Promises

The UK government’s new procurement-and-beyond body housed in the DHSC says a medtech strategy could hit the presses before 2023. The medtech industry is cheered by promises of engagement.

United Kingdom Policy

WHO’s Draft Pandemic Treaty Calls For More Regulatory Harmonization

Regulatory convergence and the sharing of dossiers, together with the timely and equitable sharing of pathogens, could help to speed up access to diagnostics, vaccines and medications in pandemic situations, according to the first draft of the World Health Organization’s proposed pandemic treaty.

International Coronavirus COVID-19

AI Screening System For Blindness Associated With Diabetes Gets FDA Nod

The US FDA has cleared an AI-based diagnostic from Israeli firm AEYE Health that screens for diabetic retinopathy, a leading cause of blindness.

FDA Artificial Intelligence

UK’s Real-World Evidence Expectations Still Not Clear To Industry

Medtech companies looking to gain reimbursement for digital products in the UK are hindered by a confusing funding system and unclear real-world evidence requirements, but improvements should be easy to implement, trade association ABHI says.

Europe EU

UK Has ‘Much Room For Improvement’ On Genomic Testing Access

UK patient outcomes would improve under clearer, standardized market access or reimbursement pathways for advanced diagnostic tests, such as those used to screen for cancer, trade groups say.

Europe EU

Future Proofing HTA: How Systems Must Adapt To AI And Digital Medtech

Artificial intelligence is a major advancement in medtech due to its ability to rapidly adapt, improve and learn. However, value assessment models must also reform to keep up with this technology in the medtech space, an HTA expert told Medtech Insight.

Medical Device Artificial Intelligence

The Case For Novel Funding Models In Digitalization Of Devices

Digitalization can offer many benefits to European health care systems, but how does this look from a payer’s perspective? A health insurance expert has made the case for bundled reimbursement models based on shared risk and investment.

EU Europe
See All
UsernamePublicRestriction

Register